Tera Science테라사이언스
073640 · KOSDAQ · ₩073640 · 테라사이언스
₩654 ₩0 (0.00%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩14B | ₩17B | ₩23B | ₩23B | ₩22B |
| Cost of sales | ₩13B | ₩15B | ₩18B | ₩19B | ₩19B |
| Gross profit | ₩1.4B | ₩2.6B | ₩4.7B | ₩4.3B | ₩3.5B |
| Operating income | −₩10B | −₩9.5B | −₩3.5B | −₩919M | −₩2.1B |
| Net income | −₩17B | −₩10B | −₩2.9B | ₩29B | −₩3.2B |
| Net income to shareholders | −₩17B | −₩9.8B | −₩2.4B | ₩29B | −₩3B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩56B | ₩79B | ₩94B | ₩108B | ₩98B |
| Current assets | ₩18B | ₩24B | ₩39B | ₩79B | ₩67B |
| Cash and equivalents | ₩2B | ₩2.9B | ₩20B | ₩34B | ₩6.5B |
| Total liabilities | ₩28B | ₩11B | ₩19B | ₩29B | ₩48B |
| Current liabilities | ₩24B | ₩8.3B | ₩16B | ₩26B | ₩46B |
| Borrowings | ₩61M | ₩3B | ₩7.4B | ₩20B | ₩37B |
| Total equity | ₩29B | ₩68B | ₩76B | ₩80B | ₩49B |
| Shareholders' equity | ₩29B | ₩67B | ₩75B | ₩80B | ₩49B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩13B | −₩3.1B | −₩4.6B | ₩357M | −₩5.1B |
| Capital spending | ₩472M | ₩267M | ₩7.4B | ₩915M | ₩1.8B |
| Free cash flow | −₩13B | −₩3.4B | −₩12B | −₩558M | −₩6.8B |
Consolidated where available. Amounts in won.
Also known as: Tera Science / 테라사이언스 / 073640 / KRX:073640
Source: KRX statistical information